Ameriprise Financial Inc Altimmune, Inc. Transaction History
Ameriprise Financial Inc
- $381 Billion
- Q3 2024
A detailed history of Ameriprise Financial Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 3,876,044 shares of ALT stock, worth $34.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,876,044
Previous 3,223,997
20.22%
Holding current value
$34.3 Million
Previous $21.4 Million
11.0%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALT
# of Institutions
186Shares Held
39.3MCall Options Held
913KPut Options Held
743K-
Black Rock Inc. New York, NY5.32MShares$47.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.98MShares$44.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.41MShares$30.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$24.3 Million1.44% of portfolio
-
Geode Capital Management, LLC Boston, MA1.67MShares$14.8 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $434M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...